Similar articles

• Interaction of the monoclonal antibodies alpha IR-1 and alpha IR-3 with insulin and somatomedin-C receptors.

  Jacobs S, Cook S, Svoboda ME, Van Wyk JJ. Jacobs S, et al. Endocrinology. 1986 Jan;118(1):223-6. doi: 10.1210/endo-118-1-223. Endocrinology. 1986. PMID: 2416553
• Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for insulin-like growth factor.

  Morgan DO, Roth RA. Morgan DO, et al. Biochem Biophys Res Commun. 1986 Aug 14;138(3):1341-7. doi: 10.1016/s0006-291x(86)80430-2. Biochem Biophys Res Commun. 1986. PMID: 3019341
• Structural differences between insulin and somatomedin-C/insulin-like growth factor-1 receptors revealed by autoantibodies to the insulin receptor.

  Jonas HA, Baxter RC, Harrison LC. Jonas HA, et al. Biochem Biophys Res Commun. 1982 Nov 30;109(2):463-70. doi: 10.1016/0006-291x(82)91744-2. Biochem Biophys Res Commun. 1982. PMID: 6295397 No abstract available.
• Insulin and insulin-like growth factor I in early development: peptides, receptors and biological events.

  de Pablo F, Scott LA, Roth J. de Pablo F, et al. Endocr Rev. 1990 Nov;11(4):558-77. doi: 10.1210/edrv-11-4-558. Endocr Rev. 1990. PMID: 1963405 Review. No abstract available.
• Insulin receptors, receptor antibodies, and the mechanism of insulin action.

  Kahn CR, Baird KL, Flier JS, Grunfeld C, Harmon JT, Harrison LC, Karlsson FA, Kasuga M, King GL, Lang UC, Podskalny JM, Van Obberghen E. Kahn CR, et al. Recent Prog Horm Res. 1981;37:477-538. doi: 10.1016/b978-0-12-571137-1.50015-3. Recent Prog Horm Res. 1981. PMID: 6269165 Review. No abstract available.